Delayed OTC Markets 5-day change 1st Jan Change
- USD -.--% Intraday chart for ReGen Biologics Inc. -.--% -

Valuation: ReGen Biologics Inc.

Market Cap 1.17M 1.03M 947K 874K 1.66M 112M 1.69M 11.31M 4.44M 55.13M 4.41M 4.31M 190M P/E 2007
-0.9x
P/E 2008 -1.66x
Enterprise Value 11.46M 10.02M 9.24M 8.54M 16.2M 1.09B 16.47M 110M 43.38M 538M 43.02M 42.09M 1.85B EV / Sales 2007
14x
EV / Sales 2008 22.7x
Free-Float
100%
Yield 2007 *
-
Yield 2008 -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 25
-0.50%-1.54%-28.85%-12.09% 164B
+1.80%+0.82%-6.73%-4.23% 107B
+0.32%+2.34%+2.79%+59.04% 59.04B
+1.74%-0.65%+39.85%+55.22% 51.72B
+0.72%-3.88%-13.66%-41.26% 41.87B
+0.47%-4.98% - - 34.7B
+2.66%+5.21%-10.09%-43.92% 28.93B
-1.10%-3.29%+55.70%-7.77% 24.99B
0.00%-1.01%-5.28%-4.72% 21.05B
Average +0.61%-1.00%+4.22%+0.03% 53.33B
Weighted average by Cap. +0.59%-0.95%-5.62%+1.24%

Financials

2007 2008
Net sales 986K 862K 796K 735K 1.39M 94.04M 1.42M 9.5M 3.73M 46.33M 3.7M 3.62M 159M 1.37M 1.2M 1.11M 1.02M 1.94M 131M 1.98M 13.25M 5.2M 64.56M 5.16M 5.05M 222M
Net income -10.38M -9.08M -8.37M -7.73M -14.67M -990M -14.92M -100M -39.28M -488M -38.96M -38.11M -1.68B -9.95M -8.7M -8.03M -7.42M -14.07M -949M -14.31M -95.93M -37.67M -468M -37.36M -36.55M -1.61B
Net Debt 4.09M 3.58M 3.3M 3.05M 5.79M 390M 5.88M 39.46M 15.49M 192M 15.37M 15.03M 661M 10.28M 9M 8.3M 7.66M 14.54M 981M 14.79M 99.15M 38.93M 483M 38.62M 37.78M 1.66B
Logo ReGen Biologics Inc.
Regen Biologics Inc (ReGen) is a United States-based development stage orthopedic products company. The Company develops, manufactures and markets tissue growth and repair products for United States and global markets. The Company's collagen matrix technology includes applications in orthopedics, general surgery, spine, cardiovascular and drug delivery. Some of these applications are marketable while others are in various stages of development. Its approved product using its collagen matrix technology is the Menaflex collagen meniscus implant device (also known as the CMI), which is marketed for sale in the European Union (EU), Switzerland, Turkey, and the Republic of South Africa, through the Company’s subsidiary, ReGen Biologics AG.
Employees
-
  1. Stock Market
  2. Stocks
  3. RGBOQ Stock